Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13,914 | $27,559 | $27,950 | $27,636 |
| Dep. & Amort. | $8,022 | $6,057 | $5,358 | $4,835 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,841 | -$6,595 | $6,834 | -$2,143 |
| Other Non-Cash | -$8,849 | -$8,661 | -$8,228 | -$7,909 |
| Operating Cash Flow | $11,246 | $18,360 | $31,914 | $22,419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$26,056 | -$12,756 | -$16,229 | -$4,185 |
| Net Acquisitions | $0 | -$11,176 | -$1,479 | $200 |
| Inv. Purchases | -$32,311 | -$49,352 | -$49,586 | -$49,467 |
| Inv. Sales/Matur. | $40,364 | $54,747 | $51,754 | $61,562 |
| Other Inv. Act. | -$412 | -$1,039 | $1,228 | -$119 |
| Investing Cash Flow | -$18,415 | -$19,576 | -$14,312 | $7,991 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$1 | -$12 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$12,000 | -$14,056 | -$3,943 |
| Dividends Paid | -$7,505 | -$7,223 | -$6,509 | -$6,251 |
| Other Fin. Act. | -$263 | -$240 | -$193 | -$171 |
| Financing Cash Flow | -$7,768 | -$19,463 | -$20,759 | -$10,377 |
| Forex Effect | $1,220 | $890 | $673 | $797 |
| Net Chg. in Cash | -$13,717 | -$19,790 | -$2,507 | $20,830 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,690 | $79,480 | $81,987 | $61,157 |
| End Cash | $45,973 | $59,690 | $79,480 | $81,987 |
| Free Cash Flow | -$15,383 | $4,791 | $15,685 | $18,234 |